Instruction to Authors

Submission Checklist

Please:

• Read the Aims and Scope carefully for an overview and assessment to find out if your manuscript is suitable for this journal.
• Paper Template can be downloaded on the webpage "Instruction to Authors" of each journal, please use the Microsoft Word template for your manuscript.
• Make sure that issues about publication ethics, copyright, authorship, figure formats, data, and references format have been considered seriously.
• Ensure that all authors have agreed on the content of the submitted manuscript.

Manuscript Submission Overview

Submission Process

IIKII journals have no limit on the length of manuscripts, but the text needs to be concise and comprehensive. Full details of experiments must be provided so that the reproduction of the results is possible. Manuscripts for IIKII journals should neither be published previously nor be considered for publication by another journal. The submitting author, as the corresponding author, is responsible for the communication and revision of the manuscript during the submission and peer-review process. The submitting author should include all eligible co-authors in the author list and have them read and approve the submitted version of the manuscript. To submit your manuscript, the submitting author must register and log in to the submission website of IIKII journals. All co-authors can see the manuscript details on the website if they register and log in using the e-mail address included in the manuscript.

Manuscripts for IIKII journals should be submitted online via submission system.

Accepted File Formats

The authors must use the Microsoft Word template for preparing their manuscripts. The template file allows shortening the time for copy-editing and publication of accepted manuscripts. A submitted manuscript must be a single file in Microsoft Word. The Microsoft Word template file should be used for manuscripts. The graphics (schemes, figures, etc.) in the main text must be inserted after the paragraph of its first citation.

We do not have strict formatting requirements, but all manuscripts must include the required sections: Author Information, Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Figures and Tables with Captions, Funding Information, Author Contributions, Conflict of Interest, and other Ethics Statements. Your references may follow the Chicago-style citation and should have consistent formatting throughout. It is mandatory to include author(s) name(s), journal or book title, article or chapter title (where required), year of publication, volume and issue (where appropriate), and pagination. DOI numbers (Digital Object Identifier) are highly encouraged. When your manuscript reaches the revision stage, you will be requested to format the manuscript according to the journal guidelines.

Cover Letter

For each manuscript submission, you must include a cover letter. The letter needs to explain the significance and findings in the context of existing work and why it fits the scope of the journal. In the cover letter, the authors must confirm that the manuscript and any parts of its content are not currently under consideration or published in another journal. Any prior submissions of the manuscript to IIKII journals also must be acknowledged. The names of proposed and excluded reviewers should be provided in the submission system, not in the cover letter.

Manuscript Preparation

General Considerations

• manuscripts should comprise:
• Frontmatter: Title, Author list, Affiliations, Abstract, Keywords
• Research manuscript sections: Introduction, Materials and Methods, Results, Discussion, and Conclusions.
• Backmatter: References, Supplementary Materials, Acknowledgments, Author Contributions, Conflicts of Interest.
• Graphical Abstract:

A graphical abstract (GA) is an image that appears alongside the text abstract in the Table of Contents. Besides summarizing content, it should represent the topic of the article in an attention-grabbing way.

The GA should be a high-quality illustration or diagram in any of the following formats: PNG, JPEG, EPS, SVG, PSD, or AI. Written text in a GA should be clear and easy to read, using one of the following fonts: Times, Arial, Courier, Helvetica, Ubuntu, or Calibri.

The required minimum size for the GA is 560 × 1100 pixels (height × width). Please make sure to keep to the same ratio for larger images.

• Abbreviations should be defined in parentheses the first time they appear in the abstract, main text, figure, table captions, and used consistently thereafter.
• SI Units (International System of Units) should be used. Imperial, US customary, and other units should be converted to SI units in all cases.
• Equations: If you are using Microsoft Word, please use either the Microsoft Equation Editor or the MathType add-on. Equations should be editable by the editorial office and not appear in a picture format.
• Research Data and supplementary materials:  For publication of the manuscript, the authors must make all materials, data, and protocols associated with the publication available to readers. Any restrictions on the availability of materials or information must be disclosed at the submission stage. The authors are encouraged to read the information about Supplementary Materials and Data Deposit for additional guidelines.
• Pre-registration: When authors have preregistered studies or analysis plans, the links to the preregistration must be provided in the manuscript.

Frontmatter

These sections should appear in all manuscript types

• Title: The title of your manuscript should be concise, specific, and relevant. It should identify if the study reports (human or animal) trial data, or is a systematic review, meta-analysis, or replication study.
• Author List and Affiliations: Authors' full first and last names must be provided. The initials of any middle names can be added. The authors need to use the PubMed/MEDLINE standard format: complete address information including city, zip code, state/province, and country. At least one author should be designated as the corresponding author whose email address and other details should be included at the end of the affiliation section.
• Abstract: The abstract should be a total of about 200 words maximum. The abstract should be a single paragraph and follow the style of structured abstract without headings: 1) Background: Write the question addressed in a broad context and highlight the purpose of the study; 2) Methods: Describe briefly the main methods or treatments applied. Include any relevant preregistration numbers and details of methods or materials (ex. species and strains of any animals used). 3) Results: Summarize the article's main findings, and 4) Conclusion: Indicate the main conclusions or interpretations. The abstract should be an objective representation of the article. It must not contain results that are not presented and substantiated in the main text and should not exaggerate the main conclusions.
• Keywords: Three to ten pertinent keywords need to be added after the abstract. The keywords must be specific to the manuscript, yet reasonably common within the subject discipline.

Research Manuscript Sections

• Introduction: The introduction should briefly describe the study in a broad context and highlight its importance. It should define the purpose of the work and its significance, including specific hypotheses being tested. The current state of the research field should be reviewed carefully and key publications cited. Please highlight controversial and diverging hypotheses when necessary. Finally, briefly mention the main aim of the work and highlight the main conclusions. The introduction must be comprehensible to scientists working outside the topic of the paper.
• Materials and Methods: Detailed explanation of materials and methods allows others to replicate and build on published results. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited. The name and version of any software, the computer code, and pre-registration codes need to be revealed for their availability.
• Results: A concise and precise description of the experimental results should be provided along with their interpretation as well as the experimental conclusions that can be drawn.
• Discussion: The authors should discuss the results and how they can be interpreted from the perspective of previous studies and of the working hypotheses. The findings and implications should be discussed in the broadest context possible and limitations of the highlighted work. Future research directions may also be mentioned. This section may be combined with Results.
• Conclusions: This section is not mandatory, but can be added to the manuscript if the discussion is unusually long or complex.
• Patents: This section is not mandatory, but may be added if patents are resulting from the work reported in this manuscript.

Backmatter

• Supplementary Materials: Any supplementary material published online alongside the manuscript (figure, tables, video, spreadsheets, etc.) may be described with the name and title of each element as follows:  Figure S1: title, Table S1: title, etc.
• Acknowledgments: All sources of funding for the study should be disclosed. Grant(s) that the authors have received in support of the research work and funds to cover publication costs should be listed. The authors should note that some funders will not refund article processing charges (APC) if the funder and grant number are not clearly and correctly identified in the paper. Funding information can be entered separately into the submission system by the authors during the submission of their manuscript. Such funding information, if available, will be deposited to FundRef if the manuscript is finally published.
• Author Contributions: Each author is expected to have made substantial contributions to the conception or design, the acquisition, analysis, interpretation of data, the creation of new software, drafting or revising the manuscript; AND has approved the submitted version (and version substantially edited by journal staff that involves the author’s contribution to the study); AND agrees to be personally accountable for the author’s contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature.
  For research articles with several authors, a short paragraph specifying their contributions must be provided. The following statements should be used "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.”. The CRediT taxonomy for the term explanation can be referred to. For more background on CRediT, authorship must include and be limited to those who have contributed substantially to the work. Please read the section concerning the criteria to qualify for authorship carefully.
• Conflicts of Interest: Authors should identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state "The authors declare no conflict of interest." Any role of the funding sponsors in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results must be declared in this section. If there is no role, please state “The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results”. For more details please see Conflict of Interest.
• References: References must be numbered in order of appearance in the text (including table captions and figure legends) and listed individually at the end of the manuscript. Preparing the references with a bibliography software package such as EndNote, ReferenceManager, or Zotero is recommended to avoid typing mistakes and duplicated references. Citations to data, computer code, and other citable research material must be referred to. If available online, you may use reference type 9 below.
• Citations and References in Supplementary files are permitted if they also appear in the main text and the reference list.
  

The reference list should include the full title, as recommended by the ACS style guide (For Journal AFM, IJCMB, and IJESP) and the APA style guide (For Journal EIET, IJBSI and IJSSAI). Style files for Endnote and Zotero are available.

ACS style: In the text, reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example [1], [1–3] or [1,3]. For embedded citations in the text with pagination, both parentheses and brackets to indicate the reference number and page numbers need to be used; for example [5] (p. 10). or [6] (pp. 101–105).

References should be described as follows, depending on the type of work:

Journal Articles:
1. Author 1, A.B.; Author 2, C.D. Title of the article. Abbreviated Journal Name Year, Volume, page range.

Books and Book Chapters:
2. Author 1, A.; Author 2, B. Book Title, 3rd ed.; Publisher: Publisher Location, Country, Year; pp. 154–196.
3. Author 1, A.; Author 2, B. Title of the chapter. In Book Title, 2nd ed.; Editor 1, A., Editor 2, B., Eds.; Publisher: Publisher Location, Country, Year; Volume 3, pp. 154–196.

Unpublished work, submitted work, personal communication:
4. Author 1, A.B.; Author 2, C. Title of Unpublished Work. status (unpublished; manuscript in preparation).
5. Author 1, A.B.; Author 2, C. Title of Unpublished Work. Abbreviated Journal Name stage of publication (under review; accepted; in press).
6. Author 1, A.B. (University, City, State, Country); Author 2, C. (Institute, City, State, Country). Personal communication, Year.

Conference Proceedings:
7. Author 1, A.B.; Author 2, C.D.; Author 3, E.F. Title of Presentation. In Title of the Collected Work (if available), Proceedings of the Name of the Conference, Location of Conference, Country, Date of Conference; Editor 1, Editor 2, Eds. (if available); Publisher: City, Country, Year (if available); Abstract Number (optional), Pagination (optional).

Thesis:
8. Author 1, A.B. Title of Thesis. Level of Thesis, Degree-Granting University, Location of University, Date of Completion.

Websites:
9. Title of Site. Available online: URL (accessed on Day Month Year).
Unlike published works, websites may change over time or disappear, so the authors must create an archive of the cited website using a service such as WebCite. Archived websites should be cited using the link provided as follows:
10. Title of Site. URL (archived on Day Month Year).

Preparing Figures, Schemes, and Tables

• File for Figures and Schemes must be provided during submission in a single zip archive and at a sufficiently high resolution (minimum 1000 pixels width/height, or a resolution of 300 dpi or higher). TIFF, JPEG, EPS and PDF are preferred though common formats are accepted.
• All Figures, Schemes, and Tables should be inserted into the main text close to their first citation and must be numbered following their number of appearance (Figure 1, Scheme I, Figure 2, Scheme II, Table 1, etc.).
• All Figures, Schemes, and Tables should have a short explanatory title and caption.
• All table columns should have an explanatory heading. To facilitate the copy-editing of larger tables, smaller fonts may be used, but no smaller than 8 pt. in size. The authors should use the Table option of Microsoft Word to create tables.
• Authors are encouraged to prepare figures and schemes in color (RGB at 8-bit per channel). There is no additional cost for publishing full-color graphics.

Research and Publication Ethics

Research Ethics

Research Involving Human Subjects

When reporting on research that involves human subjects, human material, human issues, or human data, authors must declare that the investigations were carried out following the rules of the Declaration of Helsinki of 1975 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/), revised in 2013. According to point 23 of this declaration, approval from an ethics committee should have been obtained before undertaking the research. At a minimum, a statement including the project identification code, date of approval, and name of the ethics committee or institutional review board should be cited in the Methods Section of the article. Data relating to individual participants must be described in detail, but private information identifying participants need not be included unless the identifiable materials are of relevance to the research (for example, photographs of participants’ faces that show a particular symptom). Editors reserve the right to reject any submission that does not meet these requirements.

Example of an ethical statement: "All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted under the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of XXX (Project identification code)."

Written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Patients’ initials or other personal identifiers must not appear in any images. For manuscripts that include any case details, personal information, and/or images of patients, authors must obtain signed informed consent from patients (or their relatives/guardians) before submitting to an IIKII journal. Patient details must be anonymized as far as possible, e.g., do not mention specific age, ethnicity, or occupation where they are not relevant to the conclusions. A template permission form is available to download. A blank version of the form used to obtain permission (without the patient names or signature) must be uploaded with your submission.

The author may refer to our sample form and provide an appropriate form after consulting with your affiliated institution. Alternatively, the author may provide a detailed justification of why informed consent is not necessary. For publishing in IIKII journals, a consent, permission, or release form should include unlimited permission for publication in all formats (including print, electronic, and online), in sublicensed and reprinted versions (including translations and derived works), and in other works and products under open access license. To respect patients’ and any other individual’s privacy, please do not send signed forms. The journal reserves the right to ask authors to provide signed forms if necessary.

Publication Ethics Statement

The editors of IIKII journals enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high-quality scientific works to the field of scholarly publication. The editors of IIKII journals take plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like very seriously and proceed in such cases with a zero-tolerance policy.

The authors wishing to publish their papers in IIKII journals must abide by the following:

• Any facts that might be perceived as a possible conflict of interest of the author(s) must be disclosed in the paper before submission.
• Authors should accurately present their research findings and include an objective discussion of the significance of their findings.
• Data and methods used in the research need to be presented in sufficient detail in the paper so that other researchers can replicate the work.
• Raw data should be deposited by the authors preferably and publicly before the submission of their manuscript. Authors need to at least have the raw data readily available for presentation to the reviewers and the editors of the journals if requested. Authors need to ensure appropriate measures are taken so that raw data is retained in full for a reasonable time after publication.
• Simultaneous submission of manuscripts to more than one journal is not tolerated.
• Republishing content that is not novel is not tolerated. For example, an English translation of a paper that is already published in another language will not be accepted.
• If errors and inaccuracies are found by the authors after publication of their paper, they need to promptly communicate to the editors of the journals so that appropriate actions can be taken. Please refer to our policy regarding the publication of publishing addenda and corrections.
• The manuscript should not contain any information that has already been published. If the manuscript includes already published figures or images, permission from the copyright holder to publish under the CC-BY license must be obtained. For further information, see the Rights and Permissions page.
• Plagiarism, data fabrication, and image manipulation are not tolerated.
• Plagiarism is not acceptable in submissions to IIKII journals.

Plagiarism includes copying text, ideas, images, or data from another source, even from the authors’ publications, without giving any credit to the source.

Reuse and copy of the text from another source must be between quotes and the source must be cited. If a study's design or the manuscript's structure or language has been inspired by previous works, these works must be explicitly cited.

If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, we may publish a correction or retract the paper.

• Image files must not be manipulated or adjusted in any way that could lead to misinterpretation of the information provided by the original image.
• Image manipulation includes: 1) introduction, enhancement, moving, or removing features from the original image; 2) grouping of images that should obviously be presented separately (e.g., from different parts of the same gel, or from different gels); or 3) modifying the contrast, brightness or color balance to obscure, eliminate or enhance some information.

If image manipulation is identified and confirmed during the peer review process, we may reject the manuscript. If irregular image manipulation is identified and confirmed after publication, we may correct or retract the paper.

In-house editors of IIKII will investigate any allegations of publication misconduct and may contact the authors' institutions or funders if necessary. If evidence of misconduct is found, appropriate action will be taken to correct or retract the publication. Authors are expected to comply with the best ethical publication practices when publishing in IIKII journals.

Citation Policy

Authors should ensure that where the material is taken from other sources (including their published paper(s)) the source is cited and that where appropriate permission is obtained.

Authors should not engage in excessive self-citation of their work(s).

Authors should not copy references from other publications if they have not read the cited work.

Authors should not preferentially cite their own or their friends’, peers’, or institution’s publications.

Authors should not cite advertisements or advertorial material.

Under COPE guidelines, IIKII expects that “original wording taken directly from publications by other researchers should appear in quotation marks with the appropriate citations.” This condition also applies to the author’s work. COPE has produced a discussion document on citation manipulation with recommendations for best practice.

English Corrections

Appropriate peer-reviewing of the submitted manuscript essentially requires grammatically correct English. If the author(s) is not a native English speaker, it is strongly recommended that a native English-speaking colleague edit the manuscript professionally before submission. The authors can use IIKII's English editing service. Professional editing will enable reviewers and future readers to more easily read and assess the content of submitted manuscripts. All accepted manuscripts undergo language editing, but an additional fee will be charged to the authors if very extensive English corrections must be made by the Editorial Office. Pricing is according to the service here.

Authorship

IIKII follows the International Committee of Medical Journal Editors (ICMJE) guidelines to qualify for authorship of a manuscript, the following criteria should be observed:

• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Those who contributed to the work but do not qualify for authorship should be listed in the acknowledgments. More detailed guidance on authorship is given by the International Council of Medical Journal Editors (ICMJE).

Any change to the author list should be approved by all authors including any who have been removed from the list. The corresponding author should act as a point of contact between the editor and the other authors and keep co-authors informed and involved in major decisions about the publication. IIKII reserves the right to request confirmation that all authors meet the authorship conditions.

Reviewer Suggestions

During the submission process, the authors suggest three potential reviewers with the appropriate expertise to review the manuscript. The authors need to provide detailed contact information (address, homepage, phone, e-mail address). Journal editors will check to make sure they have no conflict of interests before contacting, and will not consider those with competing interests. The suggested reviewers are asked to declare any conflicts of interest. The editors will not necessarily approach the suggested reviewers. The proposed reviewers should not be current collaborators of the co-authors, not have published with any of the co-authors of the manuscript within the last five years, and not be from different institutions to the authors. The authors may identify appropriate Editorial Board members of the journal as potential reviewers and suggest reviewers from among the authors that you frequently cite in your paper. The authors can also enter the names of potential peer reviewers they wish to exclude from consideration in the peer review of their manuscript, during the initial submission progress. The editorial team will respect these requests so long as this does not interfere with the objective and thorough assessment of the submission.

Editors and Journal Staff as Authors

Editorial independence is extremely important and IIKII does not interfere with editorial decisions. Editorial staff or editors shall not be involved in processing their academic work. Submissions authored by editorial staff/editors will be assigned to at least two independent outside reviewers. Decisions will be made by other editorial board members who do not have a conflict of interest with the author(s). Journal staff are not involved in the processing of their work(s) submitted to any IIKII journals.

Conflict of Interest

According to The International Committee of Medical Journal Editors (ICMJE), “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.”

All authors must disclose all relationships or interests that could inappropriately influence or bias their work. Examples of potential conflicts of interest include, but are not limited to financial interests (such as membership, employment, consultancies, stocks/shares ownership, honoraria, grants or other funding, paid expert testimonies, and patent-licensing arrangements) and non-financial interests (such as personal or professional relationships, affiliations, personal beliefs).

Authors can disclose potential conflicts of interest via the online submission system during the submission process. The corresponding author must include a summary statement in the manuscript in a separate section “Conflicts of Interest” placed just before the reference list. The statement should reflect all the collected potential conflict of interest disclosures in the form.

See below for examples of disclosures:

Conflicts of Interest: Author A has received research grants from Company A. Author B has received a speaker honorarium from Company X and owns stocks in Company Y. Author C has been involved as a consultant and expert witness in Company Z. Author D is the inventor of patent X.

If no conflicts exist, the authors should state:

Conflicts of Interest: The authors declare no conflicts of interest.

Publication fee:

The authors will be obliged to pay the publication fee to IIKII Pte. Ltd upon acceptance of the manuscript for publication. The publication fee is $300 USD (Free publication fee until 2024/12/31).

Editorial Procedures and Peer-Review

Initial Checks

All submitted manuscripts received by the Editorial Office will be checked by a professional in-house Managing Editor to determine whether they are properly prepared and they follow the ethical policies of the journal. Manuscripts that do not fit the journal's ethics policy or meet the standards of the journals will be rejected before peer-review. Manuscripts that are not properly prepared will be returned to the authors for revision and resubmission. After these checks, the Managing Editor will consult the journals’ Editor-in-Chief or Associate Editors to determine whether the manuscript fits the scope of the journal and it is scientifically sound. No judgment on the potential impact of the work will be made at this stage. Reject decisions at this stage will be verified by the Editor-in-Chief.

Peer-Review

A manuscript passing the initial checks will be assigned to at least two independent experts for peer-review. A single-blind review is applied with authors' identities known to reviewers. Peer review comments are confidential and will only be disclosed with the express agreement of the reviewer.

In the case of regular submissions, in-house assistant editors will invite experts with recommendations by an academic editor. These experts may also include Editorial Board members and Guest Editors of the IIKII journals. Potential reviewers suggested by the authors may also be considered. The reviewers should not have published with any of the co-authors during the past five years and should not currently work or collaborate with any of the institutions of the co-authors of the submitted manuscript.

Optional Open Peer-Review

The IIKII journals operate optional open peer-review: Authors are given the option for all review reports and editorial decisions to be published alongside their manuscript. Besides, reviewers can sign their review, i.e., identify themselves in the published review reports. Authors can alter their choice for open review at any time before publication. However, once the paper has been published, changes will only be made at the discretion of the Publisher and Editor-in-Chief. IIKII encourages authors to take advantage of optional open peer-review as proof of the rigorous process employed in publishing their research. To guarantee impartial refereeing, the names of referees would be revealed with the referees’ agreement after the paper has been accepted for publication.

Editorial Decision and Revision

All the articles, reviews, and communications published in IIKII journals go through the peer-review process and receive at least two reviews. The in-house editors will communicate to the corresponding author of the manuscript on the decision of the  reviewers which will be one of the following:

• Accept after Minor Revisions:
  The manuscript is in principle accepted after revision based on the reviewer’s comments. The authors are given five days for minor revisions.
• Reconsider after Major Revisions:
  The acceptance of the manuscript depends on the revisions. The author(s) needs to provide a point by point response or provide a rebuttal on some of the reviewer’s comments that cannot be considered for the revision. Usually, only one round of major revisions is allowed. The authors will be asked to resubmit the revised paper within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
• Reject and Encourage Resubmission:
  If additional experiments are needed to support the conclusions, the manuscript will be rejected and the authors will be encouraged to re-submit the paper once further experiments have been conducted.
• Reject:
  The manuscript has serious flaws, and/or makes no original significant contribution. No offer of resubmission to the journal is provided.

All reviewer comments should be responded to in a point-by-point way. Where the authors disagree with a reviewer, they must provide a clear response.

Author Appeals

The authors may appeal a rejection by sending an e-mail to the Editorial Office of the journal. The appeal must provide a detailed justification, including point-by-point responses to the reviewers' and/or Editor's comments. The Managing Editor of the journal will forward the appeal, the manuscript, and related information (including the identities of the referees) to the Editor-in-Chief, Associate Editor, or Editorial Board member. The academic Editor will give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage is final and cannot be reversed.

In the case of a special issue, the Managing Editor of the journal will forward the appeal, the manuscript, and related information (including the identities of the referees) to the Editor-in-Chief who will be asked to give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage will be final and cannot be reversed.

Production and Publication

Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, final corrections, pagination, and, publication on the www.iikii.com.sg  website.

• Guidelines
• Instruction to Authors
• Review process